Colgate-Palmolive (NYSE: CL) releases Q4 and 2025 earnings

Rhea-AI Filing Summary

Colgate-Palmolive Company filed a current report to furnish a press release announcing its earnings for the quarter and year ended December 31, 2025. The press release, dated January 30, 2026, is attached as Exhibit 99 and provides the company’s detailed financial results.

The earnings information is provided under Item 2.02 as furnished, not filed, which limits its use under certain securities law provisions. The filing also includes an Inline XBRL cover page data file as Exhibit 104.

0000021665False00000216652026-01-302026-01-300000021665us-gaap:CommonStockMember2026-01-302026-01-300000021665cl:A0.500NotesDue2026Member2026-01-302026-01-300000021665cl:A0300NotesDue2029Member2026-01-302026-01-300000021665cl:A1.375NotesDue2034Member2026-01-302026-01-300000021665cl:A3.250NotesDue2035Member2026-01-302026-01-300000021665cl:A0.875Notesdue2039Member2026-01-302026-01-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) January 30, 2026

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

Delaware			1-644			13-1815595
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(IRS Employer Identification No.)

300 Park Avenue,

New York,

NY

10022

(Address of Principal Executive Offices)

(Zip Code)

                                  

Registrant’s telephone number, including area code (212) 310-2000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Securities 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $1.00 par value			CL			New York Stock Exchange
0.500% Notes due 2026			CL26			New York Stock Exchange
0.300% Notes due 2029			CL29			New York Stock Exchange
1.375% Notes due 2034			CL34			New York Stock Exchange
3.250% Notes due 2035			CL35			New York Stock Exchange
0.875% Notes due 2039			CL39			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On January 30, 2026, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter and year ended December 31, 2025. This press release is attached as Exhibit 99 and is incorporated herein by reference.

The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01. Financial Statements and Exhibits.

(d)    Exhibits. The following exhibits are filed with this document:

        

Exhibit Number			Description
99			Press release, dated January 30, 2026, issued by Colgate-Palmolive Company
104			Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.                            

                                               >                 

						COLGATE-PALMOLIVE COMPANY
Date: January 30, 2026						By:    /s/ Stanley J. Sutula III
						Name: Stanley J. Sutula III
						Title: Chief Financial Officer

3

FAQ

What did Colgate-Palmolive (CL) report in its latest 8-K?

Colgate-Palmolive furnished a press release announcing its earnings for the quarter and year ended December 31, 2025. The detailed financial results are contained in that press release, which is attached to the filing as Exhibit 99 for investors to review.

Which period does Colgate-Palmolive’s January 30, 2026 earnings release cover?

The earnings release covers Colgate-Palmolive’s results for the quarter and full year ended December 31, 2025. This period aligns with the company’s fiscal year-end, and the press release describes operating performance over both the final quarter and the complete 2025 year.

How is the Colgate-Palmolive (CL) earnings information treated under securities laws?

The earnings information in this 8-K is furnished under Item 2.02, not filed, under the Securities Exchange Act of 1934. This means it is not subject to Section 18 liabilities and is not automatically incorporated into Securities Act registration statements.

What exhibits did Colgate-Palmolive include with this 8-K filing?

Colgate-Palmolive attached two exhibits: Exhibit 99, the press release dated January 30, 2026 announcing quarterly and annual earnings, and Exhibit 104, the cover page interactive data file embedded in the Inline XBRL document for electronic reporting and data analysis purposes.

Who signed Colgate-Palmolive’s January 30, 2026 Form 8-K?

The Form 8-K was signed on behalf of Colgate-Palmolive Company by Stanley J. Sutula III, the company’s Chief Financial Officer. His signature indicates the company’s authorization and acknowledgment of the accuracy of the furnished information within the scope of the report.